Developed by Ascentage Pharma, lisaftoclax is a novel orally available Bcl-2 inhibitor with clinical benefits for an array of hematologic malignancies and solid tumors. At this year's ASH Annual ...
In this interview, Tom Stepien, CEO of South 8 Technologies, discusses how the company’s innovative LiGas® technology is advancing safer lithium-ion battery solutions and addressing challenges across ...